Supplementary Table S25 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)
Year: 2026
Type: supplementary-materials
Abstract: Serious adverse events related to Delta-24-RGD in Delta-24-RGD alone (standard) cohort
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165014459
Cites:
Cited by:
Related to: